肿瘤中的免疫原性细胞死亡：概念与治疗意义

Mammalian cells responding to specific perturbations of homeostasis can undergo a regulated variant of cell death that elicits adaptive immune responses. As immunogenic cell death (ICD) can only occur in a precise cellular and organismal context, it should be conceptually differentiated from instances of immunostimulation or inflammatory responses that do not mechanistically depend on cellular demise.

Here, we critically discuss key conceptual and mechanistic aspects of ICD and its implications for cancer (immuno)therapy.